X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacology & pharmacy (15) 15
humans (13) 13
index medicus (11) 11
pharmacology (9) 9
drugs (8) 8
drug approval (6) 6
europe (6) 6
orphan drugs (6) 6
rare diseases (6) 6
dabigatran (5) 5
european union (5) 5
health care economics and organizations (5) 5
medicine, general & internal (5) 5
medicines (5) 5
cost (4) 4
critical drug evaluation (4) 4
demand-side measures (4) 4
female (4) 4
health care sciences & services (4) 4
male (4) 4
managed entry agreements (4) 4
risk (4) 4
risk assessment (4) 4
risk factors (4) 4
therapy (4) 4
adaptive pathways (3) 3
aged (3) 3
atrial-fibrillation (3) 3
biotechnology (3) 3
diffusion of innovation (3) 3
generic drugs (3) 3
generic substitution (3) 3
health aspects (3) 3
health technology assessment (3) 3
implementation (3) 3
marketing authorization (3) 3
medical and health sciences (3) 3
medical technology (3) 3
medicin och hälsovetenskap (3) 3
new models (3) 3
original research (3) 3
payers (3) 3
pharmaceuticals (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
prevalence (3) 3
reimbursement (3) 3
retrospective studies (3) 3
studies (3) 3
analysis (2) 2
animals (2) 2
anticoagulants (2) 2
atrial fibrillation (2) 2
atrial fibrillation - drug therapy (2) 2
attitudes (2) 2
basic medicine (2) 2
behavior (2) 2
cancer (2) 2
cancer drugs (2) 2
care (2) 2
clinical trials (2) 2
comparators (2) 2
cost-effectiveness (2) 2
development (2) 2
dosage (2) 2
drug approval - statistics & numerical data (2) 2
drug evaluation, preclinical - standards (2) 2
drug therapy (2) 2
education and debate (2) 2
ema (2) 2
enhance prescribing efficiency (2) 2
farmakologi och toxikologi (2) 2
future (2) 2
general practice (2) 2
gps (2) 2
health care (2) 2
health care policy (2) 2
health policy (2) 2
health policy & services (2) 2
health technology-assessment (2) 2
horizon scanning (2) 2
impact (2) 2
insulin (2) 2
interferons (2) 2
investigational therapies (2) 2
italy (2) 2
italy - epidemiology (2) 2
legislation (2) 2
leukemia (2) 2
managed entry (2) 2
managed introduction new medicines (2) 2
management (2) 2
marketing (2) 2
medical research (2) 2
medical treatment (2) 2
medicinska och farmaceutiska grundvetenskaper (2) 2
orphan drug (2) 2
orphan drug production - economics (2) 2
pharmaceutical companies (2) 2
pharmaceutical preparations (2) 2
pharmacology and toxicology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 10/2019
The Food and Drug Administration (FDA) and European Medicines Agency (EMA) now have expedited review procedures for new drugs. We compared the review times of... 
Journal Article
Farmeconomia. Health economics and therapeutic pathways, ISSN 2240-256X, 03/2013, Volume 14, Issue 2, pp. 89 - 98
The paper presents an overview of the European and Italian Regulation on Orphan Medicinal Products (OMPs), along with some data on the OMPs licensed in the EU... 
rare diseases | orphan drugs | pharmaceutical legislation
Journal Article
International Journal of Technology Assessment in Health Care, ISSN 0266-4623, 2019, Volume 35, Issue 3, pp. 189 - 194
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 05/2009, Volume 67, Issue 5, pp. 494 - 502
Journal Article
Farmeconomia. Health economics and therapeutic pathways, ISSN 1721-6915, 06/2013, Volume 14, Issue 2
Journal Article
Italian Journal of Medicine, ISSN 1877-9344, 2010, Volume 4, Issue 4, pp. 30 - 31
Journal Article
BMJ, ISSN 0959-8138, 10/2005, Volume 331, Issue 7521, pp. 895 - 897
Journal Article
International Journal of Technology Assessment in Health Care, ISSN 0266-4623, 2017, Volume 33, Issue S1, pp. 79 - 80
INTRODUCTION:Countries are struggling to fund new premium priced medicines with ever increasing prices. In addition, there are substantial savings as medicines... 
Health care | Drugs | Patents | Scanning | Risk sharing | Transplants | Pillars | Bleeding | Medicine | Tacrolimus | Risk assessment | Occupational health | Models | Cancer
Journal Article
Journal Article
Journal of clinical medicine, ISSN 2077-0383, 12/2019, Volume 9, Issue 1, p. 87
Tumor recurrence is now the leading cause of breast cancer-related death. These recurrences are believed to arise from residual cancer stem cells that survive... 
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 07/2016, Volume 7, p. 197
Journal Article